How to Buy Eli Lilly & Co Stock
Eli Lilly & Co
Eli Lilly & Co is a general drug manufacturer company located in Indiana, United States, which is part of the Healthcare sector, and is traded under the ticker LLY on the NYSE exchange.
Eli Lilly & Co stock last closed at $763.98, up 0.83% from the previous day, and has increased 75.83% in one year. It has overperformed other stocks in the Drug Manufacturers - General industry by 0.6 percentage points. Eli Lilly & Co stock is currently +81.99% from its 52-week low of $419.80, and -4.6% from its 52-week high of $800.78.
There are currently 950.41M shares of LLY outstanding. The market capitalization of LLY is $726.09B. In the last 24 hours, 1.9M LLY shares were traded.
How to Buy Eli Lilly & Co Stock
Not sure how to invest in Eli Lilly & Co stock? Here's how.
- Figure out where to buy Eli Lilly & Co stock: You need to choose an online brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you decide where to buy Eli Lilly & Co stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit funds into your brokerage account: Choose your method of payment and add your info.
- Evaluate Eli Lilly & Co stock: The Eli Lilly & Co ticker symbol is LLY. Is Eli Lilly & Co stock a good investment? Should you buy shares of LLY? How do LLY's underlying business fundamentals look? Do top analysts think Eli Lilly & Co is a good buy? Why has LLY's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if LLY is a good stock to buy).
- Make your LLY buy order: Decide if you will purchase LLY shares at the current market price or use a limit order to purchase LLY shares at a given price.
- Keep tabs on your LLY investment: Create a watchlist to get the latest news on your new investment in Eli Lilly & Co shares.
Step 1: Figure out where to buy Eli Lilly & Co stock
You need an online brokerage account to access the NYSE market and buy LLY shares.
Our favorite brokerage: eToro
Based on our research, eToro is the best stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world financial markets: From Technology to Financial Services, New York to Hong Kong — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro today.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected the right brokerage, you'll need to fill out some personal information so you are able to buy LLY stock today.
How to Set Up a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to create your new brokerage account.
- Send your data by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've finished signing up on the best free stock trading app, your next step is to transfer the money for your investment:
Watch this video walkthrough for more details depositing funds into your investment account.
Step 4: Evaluate Eli Lilly & Co stock
Once you have identified the best place to buy Eli Lilly & Co stock, it's important to research their stock before you invest, so you truly understand the risk as well as the opportunity.
Eli Lilly & Co shares quick numbers
Fundamentals of LLY
WallStreetZen was built to help part-time investors do more accurate fundamental analysis quickly.
You can view all of the due diligence checks on LLY's stock page.
Is LLY stock properly valued?
Analysts use many financial metrics, analyses, models, and charts to gauge LLY's intrinsic value.
Using relative valuations ratios:
- LLY may be overvalued based on its P/E ratio of 112.02x, relative to Drug Manufacturers - General industry P/E ratio of 31.3x
- LLY could be overvalued based on its P/B ratio of 56.67x, relative to Drug Manufacturers - General industry P/B ratio of 6.36x
- LLY may be overvalued based on its PEG ratio of 2.43x
You can access additional valuation research on LLY's stock here.
LLY Financial Summary
Positive Financial Indicators:
- Total LLY debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the LLY balance sheet.
- LLY has cash burn of 89900000. It has sufficient cash and short-term investments to cover this for at least one year.
- LLY has $2.59B in cash and short term investments. This is sufficient to cover its annual cash burn of $89.90M.
Negative Financial Indicators:
- There are more long-term liabilities than short-term assets on the LLY balance sheet.
- LLY profit margin has gone down from 20.5% to 17.1% in the past year.
- LLY has a relatively high debt to equity ratio of 3.98.
Is Eli Lilly & Co stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 15 Equities analysts who track LLY, the consensus analyst rating on Eli Lilly & Co is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they financial advice.
Most Recent LLY Analyst Upgrades/Downgrades
Chris Shibutani, a top 24% analyst from Goldman Sachs maintains LLY with a hold rating and raises their LLY price target from $650.00 to $723.00, on Apr 11, 2024.
Andrew Baum, a top 18% analyst from Citigroup maintains LLY with a strong buy rating and raises their LLY price target from $675.00 to $895.00, on Apr 2, 2024.
Citigroup's Andrew Baum raised their price target on Eli Lilly & Co (NYSE: LLY) by 32.6% from $675 to $895 on 2024/04/02. The analyst maintained their Strong Buy rating on the stock.
Baum's price target hike was based on "anticipated risk-adjusted peak sales" for Eli Lilly & Co's orforglipron, an oral small molecule GLP-1 agonist, in the mono/fixed-dose combination.
The analyst told investors that phase III trials that began recruiting patients in 2023 demonstrated efficacy in reducing drug-related hepato-toxicity.
In light of Citigroup's prediction that Lilly's peak incretin sales will exceed $85B, Baum believes the company is "ever more sensitized" to threats to its market domination posed by Novo Nordisk.
The analyst predicted that generic semaglutide will be available in China in ample quantities by the mid-term and in Western countries after 2032.
However, Baum believes that Eli Lilly and Novo Nordisk still have enough of a leg up in the market to maintain their dominating position and even increase their existing multiples.
Footnotes
Orforglipron is a non-peptide GLP1 (Glucagon-Like Peptide-1) receptor agonist developed as a weight loss drug by Eli Lilly. It is easier to produce than GLP-1 agonists on the market in 2023 and is expected to be cheaper.
GLP-1 receptor agonists reduce blood sugar and energy intake by activating the GLP-1 receptor. They mimic the actions of the endogenous incretin hormone GLP-1 released by the gut after eating.
Hepatotoxicity implies chemical-driven liver damage.
Semaglutide is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. It is a peptide similar to the hormone GLP-1, modified with a side chain.
Robyn Karnauskas, a bottom 7% analyst from Truist Securities reiterates LLY with a strong buy rating and maintains their LLY price target from $850.00 to $850.00, on Mar 22, 2024.
Geoff Meacham, a bottom 6% analyst from Bank of America maintains LLY with a strong buy rating and raises their LLY price target from $800.00 to $1,000.00, on Mar 1, 2024.
Elmar Kraus, a top 37% analyst from DZ Bank downgrades LLY to a hold rating and announces their LLY price target of $820.00, on Feb 21, 2024.
You can dig deeper into what analysts are saying on the Eli Lilly & Co stock forecast page.
LLY Technicals
LLY Growth Numbers
Last year, LLY earnings were $6.14B. In the last 5 year, LLY's earnings have increased by 1.57% per year. This was faster than the Drug Manufacturers - General industry average of 0.51%.
Last year, LLY revenue was $35.93B. In the last five year, LLY's revenue has grown by 10.69% per year. This was faster than the Drug Manufacturers - General industry average of 7.29%.
You can analyze LLY's earnings and revenue performance here.
Are LLY executives and large shareholders buying or selling the stock?
Over the past year, insiders at LLY have sold more shares than they have bought.
Kimberly H. Johnson, Director of LLY, was the latest LLY insider to buy. They bought $9,760.01 worth of LLY shares on Apr 15, 2024.
Dig into more about who owns LLY shares here.
Can I get consistent income from LLY stock?
Eli Lilly & Co pays a dividend of 0.47%, compared to the Drug Manufacturers - General industry's average dividend yield of 3.54%. If you owned $1,000 worth of LLY stock, you would have been paid $4.66 in the past 12 months.
Eli Lilly & Co dividend payments have consistently grown over the past decade and have remained stable.
Find more info about Eli Lilly & Co dividend yield and history here.
What others are saying about LLY
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Make your LLY buy order
You have two primary order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually the easiest way to buy. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a given dollar amount, place a limit order.
Click the Open button and your broker will execute the order.
If you want more info about investing in stocks on eToro, click the how to video below:
Step 6: Keep tabs on your LLY investment
Now that you own some LLY shares, you'll want to keep up with your investment.
Start a watchlist to keep tabs on your LLY stock.
LLY Feed
How to Buy Stock in Eli Lilly & Co
To reiterate, here are the 6 steps for buying Eli Lilly & Co stock:
- Figure out where to buy Eli Lilly & Co stock
- Sign up for your brokerage account
- Deposit funds into your brokerage account
- Evaluate Eli Lilly & Co stock
- Make your LLY buy order
- Keep tabs on your LLY investment
If you need a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get notifications regarding your investment in Eli Lilly & Co, hit the button below to create your watchlist.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.